| Literature DB >> 19116064 |
Eva Møller Nielsen1, Mia Torpdahl, Steen Ethelberg, Anette M Hammerum.
Abstract
The prevalence of different antimicrobial resistance profiles and variants of the Salmonella genomic island 1 (SGI1) was reported for Salmonella enterica serovar Typhimurium DT104 strains isolated from patients in Denmark. Variation in antimicrobial resistance and corresponding changes of SGI1 were shown among isolates from a foodborne outbreak.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19116064 PMCID: PMC2660706 DOI: 10.3201/eid1501.080853
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Antimicrobial resistance profile of 323 clinical Salmonella enterica serovar Typhimurium DT104 isolates, Denmark, 2003–2006*
| Phenotype | SGI1 genotype† | Unique types, no. strains (%) | All isolates, no. (%) |
|---|---|---|---|
| ACSSuT‡ | SGI1§ | 122 (84) | 251 (78) |
| ACSSuTTm¶ | SGI1-A | 5 (3) | 9 (3) |
| ASu | SGI1-B | 4 (3) | 24 (7) |
| SSu | SGI1-C | 3 (2) | 11 (3) |
| ASSuTTm | SGI1-C | 1 (0.7) | 2 (0.6) |
| ASSu | SGI1-B | 1 (0.7) | 2 (0.6) |
| ACST# | SGI1 | 1 (0.7) | 1 (0.3) |
| SSuT | Not present | 1 (0.7) | 3 (0.9) |
| Sensitive | Not present | 8 (6) | 20 (6) |
| Total | 146 (100) | 323 (100) |
*One isolate per multilocus variable number of tandem repeats analysis (MLVA) and antimicrobial resistance profile is represented in the data set of 146 strains with unique types. A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfonamides; T, tetracycline; Tm, trimethoprim. †SGI, Salmonella genomic island. Genotype determined by the SGI1-related PCR assays described in the text (1 isolate per “unique type”); see Table 2 for selected details. ‡Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin (22 strains), amoxicillin/clavulanic acid (3 strains), gentamicin (1 strain). §Only a small subset of 10 ACSSuT strains was tested by PCR for the presence of SGI1 genes. ¶Additional antimicrobial-drug resistances: nalidixic acid, ciprofloxacin, and gentamicin (1 strain). #Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin.
Characterization of Salmonella genomic island 1 in isolates with atypical antimicrobial-drug phenotype and isolates likely to be related (possible clusters or outbreaks)*
| Outbreak (no. isolates) | MLVA profile | PFGE pattern | Phenotype | SGI1 variant | Left/right junction |
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 253 | 205 | ACSSuT | SGI1 | +/+ | +/+ | + | + | + | + | + | |
| 253 | 205 | ASu | SGI1-B | +/+ | −/+ | + | − | − | + | − | |
| Pork outbreak 2003–2004 (18) | 133 | 14 | ASu | SGI1-B | +/+ | −/+ | + | − | − | + | − |
| Jun 2003 “cluster” (2) | 437 | 14 | ASu | SGI1-B | +/+ | −/+ | + | − | − | + | − |
| Jun 2003 (1) | 437 | 14 | ACSSuT | SGI1 | +/+ | +/+ | + | + | + | + | + |
| Oct 2005–Jan 2006 (8) | 443 | 14 | SSu | SGI1-C | +/+ | +/− | − | − | + | + | − |
| Jan 2006 (1) | 443 | 14 | ASSuTTm† | SGI1-C | +/+ | +/− | − | − | + | + | − |
| Dec 2003 (1) | 309 | 14 | ASSu‡ | SGI1-B | +/+ | −/+ | + | − | − | + | − |
| Sep 2006 (1) | 270 | nd | ACST | (SGI1) | +/+ | +/+ | + | + | + | + | + |
| Aug 2003 (3) | 681 | 14 | SSuT§ | − | − | − | − | − | − | − | − |
| 2003–2006 (8) | Various | Various | Sensitive | − | − | − | − | − | − | − | − |
*MLVA, multilocus variable number of tandem repeats analysis; PFGE, pulsed-field gel electrophoresis. †Other genes detected by PCR: bla, strAB, and tet(B). ‡Other genes detected by PCR: strAB and sul2. §Other genes detected by PCR: strAB sul2, and tet(A).